Who Owns APLT?

APPLIED THERAPEUTICS INC — Institutional Ownership & 13F Holdings

$0.00

+0.00 (+0.00%)

Market Cap

Shares Outstanding

Institutional Holders

90

Total Inst. Value

$51.8M

% of Float Held

QoQ Holder Change

+13

Institutional data as of Q1 2025

New Positions

14

Closed Positions

43

Increased

27

Decreased

31

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1Vestal Point Capital, LP$5.6M11,500,000
2Propel Bio Management, LLC$5.5M11,285,420
3T. Rowe Price Investment Management, Inc.$5.1M10,380,590
4BlackRock, Inc.$4.7M9,551,302
5Knoll Capital Management, LLC$3.8M7,799,687
6VANGUARD GROUP INC$2.9M5,889,193
7VR Adviser, LLC$2.7M5,567,709
8Schonfeld Strategic Advisors LLC$2.3M4,673,613
9Simplify Asset Management Inc.$2.2M4,487,505
10DEUTSCHE BANK AG\$2.2M4,466,585

Biggest Buyers & Sellers This Quarter

Top Sellers

Frequently Asked Questions

How many institutional investors hold APLT?

As of Q1 2025, 90 institutional investors report holding APLT (APPLIED THERAPEUTICS INC) in their 13F filings.

Which hedge fund owns the most APLT?

The largest institutional holder of APLT is Vestal Point Capital, LP with $5.6M in shares.

Are institutions buying or selling APLT?

This quarter, 14 institutions opened new positions in APLT and 43 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.